Glioblastoma (GBM) is the most common brain cancer in adults. Despite undergoing extensive treatment, patients with GBM typically have a dismal survival rate of only 12-16 months. Furthermore, many patients eventually experience tumor relapse. Proteins such as epigenetic modulators function to change how genes are activated in DNA without altering the genetic code. Inhibiting such […]
Read More